Q3 2024 |
289 |
$44.1B |
+$2.77B |
-$3.43B |
-$664M |
CP, SE, IBN, ICLR, TSM
|
13F-HR |
11/4/2024, 03:57 PM |
Q2 2024 |
267 |
$42.3B |
+$6.1B |
-$4.76B |
+$1.34B |
CP, ICLR, IBN, ASML, WCN
|
13F-HR |
7/31/2024, 02:12 PM |
Q1 2024 |
247 |
$42.1B |
+$4.37B |
-$1.92B |
+$2.45B |
CP, ICLR, TEAM, IBN, ASML
|
13F-HR |
4/25/2024, 02:14 PM |
Q4 2023 |
249 |
$36.2B |
+$2.81B |
-$4.48B |
-$1.66B |
CP, TEAM, ICLR, MELI, IBN
|
13F-HR |
1/29/2024, 02:04 PM |
Q3 2023 |
207 |
$34.1B |
+$3.11B |
-$1.4B |
+$1.72B |
CP, TEAM, ICLR, IBN, AON
|
13F-HR |
10/10/2023, 03:19 PM |
Q2 2023 |
217 |
$33.5B |
+$4.74B |
-$4.41B |
+$326M |
CP, AON, IBN, TEAM, ASML
|
13F-HR |
7/14/2023, 12:10 PM |
Q1 2023 |
211 |
$31.3B |
+$2.79B |
-$3.91B |
-$1.11B |
CP, TEAM, AON, IBN, MTD
|
13F-HR |
5/15/2023, 05:24 PM |
Q4 2022 |
210 |
$30B |
+$4.61B |
-$4.28B |
+$330M |
CP, AON, MTD, ACN, IBN
|
13F-HR |
2/6/2023, 05:40 PM |
Q3 2022 |
192 |
$27.9B |
+$4.37B |
-$3.3B |
+$1.07B |
CP, AON, ACN, ASML, EPAM
|
13F-HR |
10/18/2022, 03:00 PM |
Q2 2022 |
202 |
$27.9B |
+$2.61B |
-$3.65B |
-$1.04B |
CP, ASML, ACN, AON, ICLR
|
13F-HR |
8/9/2022, 03:41 PM |
Q1 2022 |
201 |
$35.8B |
+$2.03B |
-$3.58B |
-$1.56B |
CP, ASML, RMD, MTD, ACN
|
13F-HR |
5/6/2022, 03:19 PM |
Q4 2021 |
205 |
$44.4B |
+$1.67B |
-$3.61B |
-$1.94B |
TSM, ASML, SHOP, ACN, MTD
|
13F-HR |
1/26/2022, 04:24 PM |
Q3 2021 |
205 |
$43.3B |
+$4.64B |
-$1.73B |
+$2.91B |
TSM, MELI, SHOP, ASML, RMD
|
13F-HR |
11/1/2021, 06:52 PM |
Q2 2021 |
195 |
$39.4B |
+$5.27B |
-$3.54B |
+$1.73B |
TSM, SHOP, MELI, ASML, CP
|
13F-HR |
8/4/2021, 07:40 PM |
Q1 2021 |
189 |
$36.5B |
+$1.77B |
-$2.39B |
-$619M |
TSM, HDB, ASML, MELI, CP
|
13F-HR |
5/13/2021, 10:49 AM |
Q4 2020 |
193 |
$36.8B |
+$3.21B |
-$914M |
+$2.29B |
MELI, TSM, HDB, SHOP, ASML
|
Restatement |
2/23/2021, 03:34 PM |
Q3 2020 |
179 |
$28.5B |
+$2.21B |
-$2.54B |
-$337M |
TSM, MELI, SHOP, CP, ACN
|
13F-HR |
11/6/2020, 03:58 PM |
Q2 2020 |
180 |
$26.1B |
+$2.38B |
-$1.07B |
+$1.31B |
SHOP, LULU, MELI, TSM, RMD
|
13F-HR |
8/17/2020, 06:38 PM |
Q1 2020 |
180 |
$18.1B |
+$3.51B |
-$1.07B |
+$2.44B |
TSM, SHOP, LULU, CP, RMD
|
13F-HR |
5/8/2020, 04:49 PM |
Q4 2019 |
157 |
$18.6B |
+$1.82B |
-$1.68B |
+$139M |
SHOP, TSM, ACN, CP, HDB
|
Restatement |
2/13/2020, 03:46 PM |
Q3 2019 |
152 |
$16.7B |
+$1.79B |
-$737M |
+$1.06B |
CB, SHOP, ACN, TSM, HDB
|
13F-HR |
10/25/2019, 01:54 PM |
Q2 2019 |
151 |
$15.9B |
+$1.02B |
-$1.13B |
-$107M |
CB, SHOP, HDB, MTD, CP
|
13F-HR |
8/6/2019, 03:37 PM |
Q1 2019 |
142 |
$14.4B |
+$2.15B |
-$864M |
+$1.29B |
CB, SHOP, HDB, ACN, MTD
|
13F-HR |
5/13/2019, 11:43 AM |
Q4 2018 |
79 |
$11.2B |
+$1.6B |
-$30M |
+$1.57B |
HDB, SHOP, TSM, CB, CP
|
13F-HR |
2/11/2019, 03:09 PM |
Q3 2018 |
78 |
$11.2B |
+$1.29B |
-$379M |
+$907M |
TSM, SHOP, ACN, CP, CB
|
13F-HR |
11/1/2018, 03:26 PM |
Q2 2018 |
82 |
$9.67B |
+$2.14B |
-$3.08B |
-$941M |
ACN, HDB, SHOP, TSM, CB
|
Restatement |
9/18/2018, 10:12 AM |
Q1 2018 |
94 |
$10.7B |
+$1.96B |
-$261M |
+$1.7B |
CB, TSM, ACN, HDB, CP
|
13F-HR |
5/10/2018, 02:51 PM |
Q4 2017 |
96 |
$8.83B |
+$1.24B |
-$593M |
+$652M |
CB, TSM, HDB, ACN, CP
|
13F-HR |
2/6/2018, 03:08 PM |
Q3 2017 |
87 |
$7.92B |
+$1.18B |
-$129M |
+$1.05B |
CB, TSM, HDB, ACN, CP
|
13F-HR |
11/6/2017, 03:13 PM |
Q2 2017 |
84 |
$6.48B |
+$489M |
-$3.71B |
-$3.22B |
CB, TSM, HDB, ACN, CP
|
13F-HR |
8/3/2017, 04:01 PM |
Q1 2017 |
114 |
$9.24B |
+$738M |
-$514M |
+$225M |
CB, TSM, ACN, HDB, CP
|
13F-HR |
4/11/2017, 12:23 PM |
Q4 2016 |
168 |
$8.28B |
+$609M |
-$653M |
-$44M |
CB, TSM, ACN, CP, CLB
|
13F-HR |
2/1/2017, 04:15 PM |
Q3 2016 |
162 |
$8.77B |
+$3.13B |
-$838M |
+$2.3B |
CB, TSM, CP, HDB, CTRP
|
13F-HR |
10/31/2016, 11:56 AM |
Q2 2016 |
114 |
$6.27B |
+$545M |
-$886M |
-$340M |
CB, TSM, NVO, CLB, CP
|
13F-HR |
8/5/2016, 01:03 PM |
Q1 2016 |
115 |
$6.43B |
+$1.78B |
-$133M |
+$1.65B |
CB, TSM, NVO, CP, CLB
|
13F-HR |
5/9/2016, 11:00 AM |
Q4 2015 |
92 |
$4.88B |
+$1.22B |
-$538M |
+$686M |
TSM, NVO, CTRP, ICLR, CLB
|
13F-HR |
2/9/2016, 07:16 PM |
Q3 2015 |
107 |
$4.01B |
+$524M |
-$606M |
-$82.2M |
TSM, ACE, NVO, ST, ICLR
|
13F-HR |
11/6/2015, 03:09 PM |
Q2 2015 |
115 |
$4.44B |
+$1.32B |
-$1.76B |
-$443M |
TSM, NVO, ACE, ST, ASML
|
13F-HR |
8/11/2015, 03:51 PM |
Q1 2015 |
141 |
$4.94B |
+$1.67B |
-$264M |
+$1.41B |
TSM, ACE, ST, NVO, PRGO
|
13F-HR |
5/7/2015, 05:13 PM |
Q4 2014 |
114 |
$3.46B |
+$303M |
-$152M |
+$151M |
TSM, ACE, PRGO, ST, ASML
|
13F-HR |
2/9/2015, 04:10 PM |
Q3 2014 |
113 |
$3.24B |
+$315M |
-$1.05B |
-$731M |
TSM, CP, CNI, ACE, NVO
|
13F-HR |
11/10/2014, 03:54 PM |
Q2 2014 |
141 |
$4.01B |
+$1.26B |
-$57.3M |
+$1.2B |
TSM, NVO, CP, ACE, CNI
|
13F-HR |
8/8/2014, 01:14 PM |
Q1 2014 |
138 |
$2.79B |
+$167M |
-$243M |
-$76.1M |
TSM, NVO, ACE, PRGO, CP
|
13F-HR |
5/8/2014, 04:40 PM |
Q4 2013 |
133 |
$2.71B |
$0 |
$0 |
|
TSM, ACE, PRGO, CNI, CP
|
Restatement |
2/21/2014, 05:07 PM |